Lautenbach E - Search Results

1

Is there cross-reactivity between penicillins and cephalosporins?

Apter AJ, Kinman JL, Bilker WB, Herlim M, Margolis DJ, Lautenbach E, Hennessy S, Strom BL. Apter AJ, et al. Among authors: lautenbach e. Am J Med. 2006 Apr;119(4):354.e11-9. doi: 10.1016/j.amjmed.2005.10.052. Am J Med. 2006. PMID: 16564780

2

The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus.

Lautenbach E, Schuster MG, Bilker WB, Brennan PJ. Lautenbach E, et al. Clin Infect Dis. 1998 Nov;27(5):1259-65. doi: 10.1086/515002. Clin Infect Dis. 1998. PMID: 9827280

3

Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality.

Lautenbach E, Bilker WB, Brennan PJ. Lautenbach E, et al. Infect Control Hosp Epidemiol. 1999 May;20(5):318-23. doi: 10.1086/501624. Infect Control Hosp Epidemiol. 1999. PMID: 10349947

4

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.

Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Lautenbach E, et al. Clin Infect Dis. 2001 Apr 15;32(8):1162-71. doi: 10.1086/319757. Epub 2001 Mar 26. Clin Infect Dis. 2001. PMID: 11283805

5

Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO. Lautenbach E, et al. Clin Infect Dis. 2001 Oct 15;33(8):1288-94. doi: 10.1086/322667. Epub 2001 Sep 14. Clin Infect Dis. 2001. PMID: 11565067

6

Trends in antimicrobial susceptibility patterns among inpatient enterococcal isolates (1990 to 1999): implications for therapeutic options.

Lautenbach E, Patel JB, Bilker WB, Fishman NO. Lautenbach E, et al. Infect Control Hosp Epidemiol. 2002 Aug;23(8):416-8. doi: 10.1086/503470. Infect Control Hosp Epidemiol. 2002. PMID: 12186203 No abstract available.

7

Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections.

Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein PH, Strom BL. Lautenbach E, et al. Arch Intern Med. 2002 Nov 25;162(21):2469-77. doi: 10.1001/archinte.162.21.2469. Arch Intern Med. 2002. PMID: 12437407

8

Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins.

Lautenbach E, LaRosa LA, Marr AM, Nachamkin I, Bilker WB, Fishman NO. Lautenbach E, et al. Clin Infect Dis. 2003 Feb 15;36(4):440-6. doi: 10.1086/346153. Epub 2003 Jan 24. Clin Infect Dis. 2003. PMID: 12567301

9

Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics.

Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, Bilker WB, Pettitt D. Strom BL, et al. Among authors: lautenbach e. N Engl J Med. 2003 Oct 23;349(17):1628-35. doi: 10.1056/NEJMoa022963. N Engl J Med. 2003. PMID: 14573734 Free article.

10

Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms.

Lautenbach E, Strom BL, Nachamkin I, Bilker WB, Marr AM, Larosa LA, Fishman NO. Lautenbach E, et al. Clin Infect Dis. 2004 Mar 1;38(5):655-62. doi: 10.1086/381549. Epub 2004 Feb 17. Clin Infect Dis. 2004. PMID: 14986249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

358 results

Search Page

Filters